Anti‐hypertensive effect and potential mechanism of gastrodia‐uncaria granules based on network pharmacology and experimental validation
The Journal of Clinical Hypertension · 2024
DOI: 10.1111/jch.14833 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2024. Verfasst von Chu-Hao Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, National Research Centre for Tran…. Hauptthemen laut MEDLINE: Hypertension, Network Pharmacology, Antihypertensive Agents, Molecular Docking Simulation. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Sailing Program, Natural Science Foundation of Shanghai, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypertension has become a major contributor to the morbidity and mortality of cardiovascular diseases worldwide. Despite the evidence of the anti‐hypertensive effect of gastrodia‐uncaria granules (GUG) in hypertensive patients, little is known about its potential therapeutic targets as well as the underlying mechanism. GUG components were sourced from TCMSP and HERB, with bioactive ingredients screened. Hypertension‐related targets were gathered from DisGeNET, OMIM, GeneCards, CTD, and GEO. The STRING database constructed a protein–protein interaction network, visualized by Cytoscape 3.7.1. Core targets were analyzed via GO and KEGG using R package ClusterProfiler. Molecular docking with AutodockVina 1.2.2 revealed favorable binding affinities. In vivo studies on hypertensive mice and rats validated network pharmacology findings. GUG yielded 228 active ingredients and 1190 targets, intersecting with 373 hypertension‐related genes. PPI network analysis identified five core genes: AKT1, TNF‐α, GAPDH, IL‐6, and ALB. Top enriched GO terms and KEGG pathways associated with the anti‐hypertensive properties of GUG were documented. Molecular docking indicated stable binding of core components to targets. In vivo study showed that GUG could improve vascular relaxation, alleviate vascular remodeling, and lower blood pressure in hypertensive animal models possibly through inhibiting inflammatory factors such as AKT1, mTOR, and CCND1. Integrated network pharmacology and in vivo experiment showed that GUG may exert anti‐hypertensive effects by inhibiting inflammation response, which provides some clues for understanding the effect and mechanisms of GUG in the treatment of hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University Scho…
ORCID-Profile: Chu-Hao Liu, Qi-Qi Xue, Yi-Qing Zhang, Dong-Yan Zhang, Yan Li
Förderung
- Shanghai Sailing Program
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Ministry of Science and Technology
- Shanghai Commissions of Health
- the Shanghai Municipal Administrator of Traditional Chinese Medicine
- Natural Science Foundation of Shanghai Municipality
- Ministerio de Ciencia y Tecnología
Zitieren
APA
Liu, C. H., Xue, Q. Q., Zhang, Y. Q., Zhang, D. Y., & Li, Y. (2024). Anti‐hypertensive effect and potential mechanism of gastrodia‐uncaria granules based on network pharmacology and experimental validation. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14833
Vancouver
Liu CH, Xue QQ, Zhang YQ, Zhang DY, Li Y. Anti‐hypertensive effect and potential mechanism of gastrodia‐uncaria granules based on network pharmacology and experimental validation. The Journal of Clinical Hypertension. 2024. doi:10.1111/jch.14833
BibTeX
@article{Liu2024,
author = {Liu, Chu-Hao and Xue, Qi-Qi and Zhang, Yi-Qing and Zhang, Dong-Yan and Li, Yan},
title = {Anti‐hypertensive effect and potential mechanism of gastrodia‐uncaria granules based on network pharmacology and experimental validation},
journal = {The Journal of Clinical Hypertension},
year = {2024},
doi = {10.1111/jch.14833}
}
EUVIMED